2011-05-24 09:00 Attana AB Attana Cell 200 - Bridging the gap between traditional biosensors and cell-based assays! Drug development is costly and risky and the need for technologies that accelerate the process of drug discovery becomes increasingly urgent. This paper shows four instances of how the Attana Cell 200 biosensor provides data enhancing the ability to select the right drug candidates earlier in the process.
2011-01-26 08:53 Attana AB The journal IPT features an article written by Attana's product manager where he discusses how to achieve biological relevance during research and the benefits of doing so. The article is also available online, see right for link.
2010-11-11 09:02 Attana AB Kinetics on cells using the Attana Cell 200 - two application examples easily explained in Attana's new poster. Select the right candidate early by getting biologically relevant data from interactions directly on the cell surface.
2010-06-23 08:46 Attana AB The objective of this application note was to determine the binding properties of the lectin ConA towards human epidermoid carcinoma cells. Among other things it was found that a kinetic approach may be used to determine the apparent affinity and rate constants of lectin-cell glycan interactions, providing a greater understanding of the mechanism involved in the lectin recognition of cancer cells.
2010-06-16 09:42 Attana AB The objective of this application note was to evaluate newly developed therapeutic antibodies in a biologically relevant context (cells) in order to detect failing candidates at an earlier stage. Among other things, it was found that real-time screening of drug candidates in a synthetic and in a cellular context together provides highly informative and biologically relevant data.
2010-06-09 08:34 Attana AB The objective of this application note was to determine the glycosylation profile of cancer cells using a cell based QCM Biosensor assay. Among other things, it was found that a single surface can be used to perform lectin screening and to provide a highly relevant and reproducible determination of the glyco-profile of cancer cells.
2010-02-01 14:45 Attana AB Attana AB lanserar Attana Cell 200 - ett banbrytande mätinstrument som tar läkemedelsutvecklingen ett steg närmare kroppen.